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Background: Recently, we introduced the complete genome sequence of Mycobacterium massiliense clinical
isolates, Asan 50594 belonging to Type II genotype with rough colony morphology. Here, to address the issue of
whether the rough colony morphotype of M. massiliense Type II genotype is genetically determined or not, we
compared polymorphisms of the glycopeptidolipid (GPL) gene locus between M. massiliense Type II Asan 50594
and other rapidly growing mycobacteria (RGM) strains via analysis of genome databases.
Results: We found deletions of 10 genes (24.8 kb), in the GPL biosynthesis related gene cluster of Asan 50594
genome, but no deletions in those of other smooth RGMs. To check the presence of deletions of GPL biosynthesis
related genes in Mycobacterium abscessus − complex strains, PCRs targeting 12 different GPL genes (10 genes
deleted in Asan 50594 genome as well as 2 conserved genes) were applied into 76 clinical strains of the M. abscessus
complex strains [54 strains (Type I: 33, and Type II: 21) of M. massiliense and 22 strains (rough morphoype: 11 and
smooth morphotype: 11) of M. abscessus]. No strains of the Type II genotype produced PCR amplicons in a total of 10
deleted GPL genes, suggesting loss of GPL biosynthesis genes in the genome of M. massiliense type II genotype strains.
Conclusions: Our data suggested that the rough colony morphotype of the M. massiliense Type II genotype may be
acquired via deletion events at the GPL gene locus for evolutionary adaptation between the host and pathogen.
Keywords: Mycobacterium massiliense, Glycopeptidolipid (GPL), Rough colony morphotype, GPL biosynthesis related
genes, Comparative genomicsBackground
Rapidly growing mycobacteria (RGM) infections in im-
munocompetent persons, as well as in persons with pre-
disposing factors or who are immunosuppressed, are
being reported more frequently [1,2]. Particularly, of the
RGMs, Mycobacterium abscessus − complex is commonly
associated with wound infections and abscess formation
and is the most frequent RGM causing chronic lung
disease [3,4]. Recent application of the combinatorial
taxonomy including biochemical tests, anti-microbial sus-
ceptibility test, and multi-locus sequencing approach have* Correspondence: kbumjoon@snu.ac.kr
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stated.suggested that the M. abscessus − complex is actually sub-
divided into three species: Mycobacterium abscessus
subsp. abscessus, M abscessus subsp. massiliense, and M.
abscessus subsp. bolletii; which exhibit clinically relevant
differences in their antibiotic sensitivity profiles [5-7]. In
South Korea, infection by members of the M. abscessus −
complex is the most prevalent of RGM infections and
second to the M. avium − complex of non-tuberculous
mycobacteria (NTM) [8].
NTM has long been known to have both rough and
smooth colony phenotypes [9,10]. This may be due
mainly to the expression levels of glycopeptidolipids
(GPLs). GPLs are produced by several NTMs, including
RGMs, such as M. abscessus, M. chelonae and M. smeg-
matis, [11-13] and M. avium − complex (MAC) mem-
bers, such as M. avium and M. intracellulare [14-16].
GPLs are responsible for smooth colonies and contribute
to colonization of NTMs in the environment via biofilm. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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colonies and facilitates survival in macrophages [17].
In the M. abscessus − complex strains, smooth pheno-
types have occasionally spontaneously reverted to rough
morphotypes after several passages on agar plates or via
in vivo passage into mice [17]. It was reported that there
is a positive correlation between colony morphology and
virulence, with rough variants generally being more viru-
lent than smooth variants [17,18]. This may be due pri-
marily to the reduced expression of GPL, resulting in
excessive secretion of TNF-α by the macrophage [18].
Recently, targeted deletion of a gene, mmpL4b, in the M.
abscessus is also reported to lead to loss of GPL and to
show enhanced invasive abilities [19].
A recent molecular epidemiology study based on partial
hsp65 sequences (603 bp) indicated that M. massiliense
(65/109 patients, 59.6%) of M. abscessus complex strains
was more prevalent than M. abscessus (44/109 patients,
40.4%) in South Korea [20]. Interestingly, infections in 30
of 65 Korean patients (46.2%) with M. massiliense, were
found to be caused by a distinct Type II genotype not en-
countered in other areas [20].
The most characteristic feature of this novel genotype
is that all its strains showed the rough colony morpho-
type. This suggests that its rough colony phenotype may
be due to an irreversible genetic factor rather than the
reversible spontaneous reversion from smooth to rough
morphotype previously introduced as a major mechanism
for acquisition of the rough phenotype in M. abscessus −
complex strains [17].
The aim of this study was to prove our hypothesis that
the rough colony phenotype of the new M. massiliense
Type II genotype may be genetically determined. For this
purpose, we first compared the GPL biosynthesis related
gene loci of M. massiliense Asan 50594, belonging to the
Type II genotype for which we recently provided a
complete genome, with those of other RGMs [21]. Sec-
ond, to check whether GPL deletion is distinct for M.
massiliense Type II genotype of M. abscessus − complex
strains, PCR assays for the detection of GPL deletions
were applied to the M. abscessus complex clinical
strains, including a variety of groups.
Results
Differences between GPL expression patterns of
M. massiliense Type I and Type II strains
To check out the differences in the GPL expression pat-
terns of M. massiliense Type I and Type II strains, puri-
fied GPLs were examined and analyzed using matrix
assisted laser desorption ionization-time of flight mass
spectrometry (MALDI-TOF MS). Pronounced differ-
ences in the MALDI-TOF MS profiles were found be-
tween the GPLs of the two genotypes. In the case of M.
massiliense Type I strain Asan 51843, the MALDI-TOFMS profiles showed two distinct clusters of peaks ran-
ging from m/z 1101 to m/z 1245 and from m/z 1287 to
m/z 1419, corresponding to diglycosylated GPL and tri-
glycosylated GPL, respectively (Figure 1A). All four of
the other Type I strains also showed MALDI-TOF mass
spectrometry profiles similar to Strain 51843 (Additional
file 1). However, the MALDI-TOF MS profiles of GPLs
from M. massiliense Type II Asan 50594, were showed
unusual, with significantly lower intensity of the peaks
corresponding to the putative GPLs, compared to the
profiles of the Type I strains (Figure 1B). Also, all four of
the other Type II strains showed MALDI-TOF MS pro-
files similar to Strain 50594 (Additional file 1). This
means that there was loss of GPLs in the cell wall com-
ponents of the M. massiliense Type II strains.
Comparative genomic analysis of the GPL biosynthesis
related locus
To check out whether the GPL loss in M. massilienseType
II is genetically determined or not, we performed com-
parative genomic analysis of 29 GPL biosynthesis related
genes (one larger cluster of ~40 kbp covering 19 genes,
one smaller cluster of ~19 kbp covering 6 genes and four
distributed genes in M. abscessus) from M. massiliense
Type II Asan 50594 (GenBank Accession No., CP004374)
and four other RGMs, [M. abscessus CIP 104536T (Gen-
Bank Accession No., NC_010397), M. massiliense CCUG
48898T (GenBank Accession No., AKVF00000000), M.
chelonae CIP 104535T (GenBank Accession No., AM231610-
AM231615), and M. smegmatis str MC2 155 (GenBank
Accession No., AY439015)] [13,21,22].
When compared with M. abscessus CIP 104536T and
M. massiliense CCUG 48898T, or M. massiliense Type II
Asan 50594, the percentage of identity of amino acids
between 2 strains ranges between 86 and 100% (Table 1).
Similar to the M. abscessus CIP 104536T, M. massiliense
CCUG 48898T or M. massiliense Type II Asan 50594
have GPL biosynthesis related genes which were divided
into two clusters. In the genome of M. massiliense Type
II Asan 50594, one cluster of ~11 kbp covering 8 genes
(from MASS_4108 to MASS_4116, counterparts for gap
to mmpS4 in M. abscessus), one cluster of ~19 kbp cov-
ering 6 genes (from MASS_0918 to MASS_0923, coun-
terparts for gap-like to pks in M. abscessus) and five
distributed genes (MASS_4474, 4488, 4493, 4660 and
4722, counterparts for fadE5, sap, ecf, Rv0926 and mbtH
in M. abscessus, respectively) were found among the
GPL-biosynthesis related genes. Interestingly, compared
to other RGMs, there are no counterparts of 10 GPL bio-
synthesis related genes in the genome of M. massiliense
Type II Asan 50594 (Table 1, Figure 2). All the deleted
genes were found in the region corresponding to the first
larger GPL cluster in M. abscessus CIP 104536T or M.
massiliense CCUG 48898T. Genes atf1 and atf2, which are
Figure 1 MALDI-TOF MS analysis of extracted GPLs from: (A) M. massiliense Type I Asan 51843, (B) M. massiliense Type II Asan 50594.
Abbreviations: DG, diglycosylated GPLs; TG, triglycosylated GPLs; PIM2, phosphatidylinositol dimannoside.
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involved in the glycosylation of the lipopeptide core
[24,25]; rmt2, rmt3, and rmt4, which are involved in the
O-methylation of the various hydroxyl groups of the
rhamnosyl unit; fmt, which is also involved in the O-
methylation of the lipid moiety [26-28]; and mps1 and
mps2, which are responsible for assembling the tripeptide-
aminoalcohol moiety [29], were deleted from the GPL
locus of M. massiliense Type II Asan 50594 (Table 1,
Figure 2 and Figure 3).
Considering that GPLs are related to formation of
smooth colonies, these deletions represent the phenotypiccharacteristics of M. massiliense Type II, which only oc-
curred in rough colonies [20].
PCR confirmation of GPL biosynthesis related genes from
M. massiliense and M. abscessus clinical isolates
To check the presence of the GPL biosynthesis related
genes from M. massiliense and M. abscessus clinical iso-
lates, DNAs from 76M. abscessus related strains were
amplified by PCRs using 12 primer sets (Additional file 2),
which targets 10 deleted genes in Asan 50594 genome:
atf1, atf2, fmt, gtf1, gtf2, rmt2, rmt3, rmt4, mps1, and mps2
and 2 conserved genes as PCR positive controls: gap and
Table 1 GPL biosynthesis related genes of M. abscessus, M. massiliense, M. massiliense type II, M. chelonae and M.
smegmatis
M. abscessusa M. massilienseb M. massiliense
Type IIc
M. chelonaed M. smegmatise
Gene Locus_tag Description Locus_tag ID (%) Locus_tag ID (%) Locus_tag ID (%) Locus_tag ID (%)
mmpS4 MAB_4117c Putative membrane protein,
MmpS family
MMAS_40600 100 MASS_4116 100 MC1618 95 MSMEG0373 78
mmpL4a MAB_4116c Putative membrane protein, MmpL MMAS_40590 100 MASS_4115 100 MC1619 95 MSMEG0374 78
mmpL4b MAB_4115c Putative membrane protein, MmpL MMAS_40580 99 MASS_4114 99 MC1620 92 MSMEG0375 76
Rv1174 MAB_4114c Conserved hypothetical protein MMAS_40570 99 MASS_4113 99 MC1621c 89 MSMEG0376 48
rmlA MAB_4113 Glucose-1-phosphate
thymidylyltransferase
MMAS_40560 100 MASS_4112 100 MC1622c 97 MSMEG0377 85
gtf3 MAB_4112c Putative glycosyltransferase GtfA MMAS_40540 98 MASS_4110 99 MC1623 88 MSMEG0378 70
rmlB MAB_4111c Putative epimerase/dehydratase MMAS_40530 99 MASS_4109 99 MC1624 93 MSMEG0379 78
atf2 MAB_4110c Probable acetyltransferase AtfA MMAS_40520 97 MC1625 89
rmt2 MAB_4109c Putative methyltransferase MMAS_40510 98 MC1626 82 MSMEG0380 72
rmt4 MAB_4108c Methyltransferase MtfB MMAS_40500 99 MC1627 96 MSMEG0381 83
gtf1 MAB_4107c Glycosyltransferase GtfA MMAS_40490 99 MC1628 92 MSMEG0382 76
atf1 MAB_4106c Acetyltransferase MMAS_40480 98 MC1629 89 MSMEG0383 72
rmt3 MAB_4105c Methyltransferase MtfD MMAS_40470 100 MC1630 92 MSMEG0384 81
gtf2 MAB_4104c Putative glycosyltransferase GtfB MMAS_40460 97 MC1631c 81 MSMEG0385 67
fmt MAB_4103c Probable methyltransferase MMAS_40450 99 MC1632 85 MSMEG0386 68
mbtH MAB_4100c MbtH-like protein MMAS_40430 99 MASS_4722 86 MC1635 100 MSMEG0387 91
mps1 MAB_4099c Probable non-ribosomal
peptide synthetase
MMAS_40410 99 MC1636 86 MSMEG0390 70
mps2 MAB_4098c Probable peptide synthetase NRP MMAS_40400 99 MC1637 91 MSMEG0392 72
gap MAB_4097c Conserved hypothetical protein MMAS_40390 99 MASS_4108 99 MC1638 85 MSMEG0393 58
sap MAB_4454c Conserved hypothetical
protein (DGPF family)
MMAS_43620 99 MASS_4488 98 MC1299 94 MSMEG0394 31
ecf MAB_4459c RNA polymerase sigma-70 factor,
ECF subfamily
MMAS_43670 98 MASS_4493 96 MC1294 85 MSMEG0395 47
fadE5 MAB_4437 Probable acyl-CoA
dehydrogenase FadE
MMAS_43460 99 MASS_4474 99 MC1318c 96 MSMEG0396 78
Rv0926 MAB_4633 Conserved hypothetical protein MMAS_45360 99 MASS_4660 99 MC1136c 91 MSMEG0397 36
pks MAB_0939 Probable polyketide synthase MMAS_07820 99 MASS_0923 98 MC0819 90 MSMEG0398 79
papA3 MAB_0938c Probable conserved polyketide
synthase associated protein PapA3
MMAS_07800 99 MASS_0922 99 MC0818c 92 MSMEG0399 78
mmpL10 MAB_0937c Putative membrane protein,
MmpL family
MMAS_07790 99 MASS_0921 99 MC0817c 95 MSMEG0400 75
PE MAB_0936c Conserved hypothetical protein MMAS_07780 99 MASS_0920 99 MC0816c 89 MSMEG0402 64
fadD23 MAB_0935c acyl-CoA synthetase MMAS_07770 99 MASS_0919 99 MC0815c 88 MSMEG0401 73
gap-like MAB_0934 Conserved hypothetical integral
membrane protein
MMAS_07760 98 MASS_0918 98 MC0814 88 MSMEG0403 54
aAccession number: NC_010397 (13).
bAccession number: AKVF00000000 (24).
cAccession number: CP004374 (20).
dAccession number: AM231610-AM231615 (13).
eAccession number: AY439015 (13).
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abscessus related strains including Asan 50594. Of 76
strains, 21 strains of M. massiliense Type II were not amp-
lified by PCRs targeting 10 deleted genes in Asan 50594genome, but amplified by PCRs targeting 2 conserved
genes, suggesting the loss of corresponding GPL genes in
all 21M. massiliense Type II strains. But, all the remaining
55 strains were positively amplified by PCRs targeting 10
Figure 2 Organization of GPL biosynthesis related genes. Color code: Light blue – mmpL family; black – unknown; purple – sugar biosynthesis,
activation, transfer and modifications; red – lipid biosynthesis, activation, transfer and modifications; green – pseudopeptide biosynthesis; yellow –
required for GPL transport to the surface; grey – regulation.
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presence of targeted GPL biosynthesis genes in their gen-
ome. It should be noted that all the 23 strains with rough
colony morphotype (12M. massiliense Type I and 11M.







Figure 3 Schematic representation of the structure of the GPLs from
in brackets and the genes deleted in M. massiliense Type II Asan 50594, are
methyl; dTal, 6-deoxytalose; D-Rha, rhamnose of the D series.produced positive amplifications in PCRs targeting 10 de-
leted genes, suggesting there may be the disparity between
M. massiliense Type II and other related strains in mech-
anism leading to rough colony phenotype (Figure 4,








M. smegmatis (13). The genes involved in GPL synthesis are indicated
indicated with strikethrough line. Abbreviations: OAc, acetyl; OMe,
Figure 4 Confirmation of deleted GPL biosynthesis related genes by PCR among clinically isolated M. massiliense and M. abscessus.
M, 100 bp DNA ladder; Lane 1, M. massiliense Type I Asan 51843; Lane 2, M. massiliense Type I Asan 50375; Lane 3, M. massiliense Type I Asan 15;
Lane 4, M. massiliense Type II Asan 50594; Lane 5, M. massiliense Type II Asan 52012; Lane 6, M. massiliense Type II Asan 1; Lane 7, M. massiliense
Type I (rough) Asan 22; Lane 8, M. massiliense Type I (rough) Asan 23; Lane 9, M. massiliense Type I (rough) Asan 54790; Lane 10, M. abscessus
(smooth) Asan 57214; Lane 11, M. abscessus (smooth) Asan 57388; Lane 12, M. abscessus (smooth) Asan 58417; Lane 13, M. abscessus (rough) Asan
55088; Lane 14, M. abscessus (rough) Asan 56232; Lane 15, M. abscessus (rough) Asan 56544; N, negative control.
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Infection by M. massiliense strains of RGMs has gained
importance together with its increasing prevalence over
the world [30-35]. In particular, a recent study based on
whole genome sequencing revealed the first evidence of
human to human transmission in NTM infection, by
proving its transmission between cystic fibrosis patients;
suggesting unusually high infectivity of humans by M.
massiliense strains [36]. In South Korea, a distinct epide-
miologic trend was reported [37], of higher prevalence
of M. massiliense strains (of the M. abscessus − complex);
part of which may be attributed to the presence of the
M. massiliense Type II genotype found only in Korean
patients [20].
The combination of our genomic and molecular epide-
miologic data in this study proved that all the strains be-
longing to a novel M. massiliense Type II genotype,showed loss of genes related to GPL biosynthesis (10 of
29 consecutive genes in M. abscessus) (Table 1, Figure 2
and Figure 3), resulting in irreversible rough phenotypes.
Our PCR data targeting 12 GPL biosynthesis genes sug-
gested that there may be the disparity between 2 groups,
M. massiliense Type II and other M. abscessus related
strains in evoking rough colony phenotypes. Unlike the
former acquiring rough phenotype via a genetically de-
termined mechanism, it cannot be excluded that GPL
loss of the latter may be mediated by a not-yet deter-
mined non-genetic mechanism leading to the transient
GPL loss, as reported in other papers [17]. But, the exact
mechanism related to rough colony phenotype of the lat-
ter has to be elucidated in the future.
To our knowledge, this is the first report regarding
this genetic defect of GPL biosynthesis in NTMs. Unlike
for the M. tuberculosis − complex strains capable of
Table 2 PCR results of deleted or conserved genes at the GPL biosynthesis related locus from M. massiliense Type I, M.
massiliense Type II, M. massiliense Type I (rough colony morphology), and M. abscessus (smooth and rough colony
morphology), strains











Deleted genes in M. massiliense Type II strain atf1 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
atf2 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
fmt 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
gtf1 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
gtf2 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
mps1 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
mps2 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
rmt2 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
rmt3 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
rmt4 21/21 (100) 0/21 (0) 12/12 (100) 11/11 (100) 11/11 (100)
Conserved genes gap 21/21 (100) 21/21 (100) 12/12 (100) 11/11 (100) 11/11 (100)
rmlB 21/21 (100) 21/21 (100) 12/12 (100) 11/11 (100) 11/11 (100)
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can infect humans only from environmental sources, al-
though infection between cystic fibrosis patients by M.
abscessus − complex strains has recently been reported
[36]. Therefore, GPL is generally necessary for NTM
survival in the natural environment (soils and water),
and for human infection from environmental sources
[17,23]. Particularly, in M. abscessus strains, the change
of colony morphology from smooth to rough type, which
provides an advantage for survival within a host macro-
phage, has so far been reported to happen spontaneously
after host infection by reduction of GPL expression; not
by irreversible genetic loss [17,36].
Given that M. tuberculosis − complex strains are strict
pathogens that do not harbor gene loci related to GPL bio-
synthesis within their genomes, it is inferred that strains
belonging to the M. massiliense Type II genotype may be
more adapted to human infection than other members of
M. abscessus complex. After sub-cultures of more than 10
generations on 7H9 broth or 7H10 agar plates, the rever-
sion of rough to smooth type was not found in any Type
II strains (data not shown). This further supports our hy-
pothesis that the rough morphotype of Type II, like M.
tuberculosis, may be an innate (genetic) trait derived from
a smooth strain by evolutionary events, rather than a tran-
sient trait acquired during an in vivo infection.
Collectively considering our data only for the selective
separation of the M. massiliense Type II genotype, we
recommended combinatorial PCRs targeting both GPL
deletion and conserved genes (e.g., hsp65), because they
can be used for simple separation of the genotypes with-
out additional procedures such as sequencing or PCR re-
striction analysis.Conclusions
In conclusion, our data showed that the M. massiliense
Type II genotype showed gene loss related to GPL bio-
synthesis within its genome, resulting in a rough colony
phenotype. To our knowledge, this is the first report of
an NTM with a rough colony phenotype genetically de-
termined by GPL gene loss.
Methods
Bacterial strains
All clinically isolated M. abscessus and M. massiliense [20]
used in this study were cultured in 7H9 broth supple-
mented with 10% ADC at 37°C for 3 days. For MALDI-
TOF analysis, five M. massiliense Type I (50375, 51843,
52352, Asan 7 and Asan 15) and five M. massiliense Type
II (50594, 51048, 52012, Asan 1 and Asan 19) strains were
used. For the PCR confirmation of GPL biosynthesis-
related genes, a total of 76 strains [M. massiliense Type I
(21 strains), M. massiliense Type II (21 strains), rough M.
massiliense Type I (12 strains), smooth M. abscessus (11
strains) and rough M. abscessus (11 strains)] were used
and listed in Table 3 and Additional file 4. All clinical
strains were selected from among the 109 strains used in
the previous report [20]. Separation of all M. abscessus −
complex strains into genotypes or subspecies was per-
formed by 603-bp hsp65 based sequence analysis as
described previously [20].
Glycopeptidolipid (GPL) extraction
To characterize the GPL profiles of the M. massiliense
Type I and Type II strains, five Type I (50375, 51843,
52352, Asan 7 and Asan 15) or Type II (50594, 51048,
52012, Asan 1 and Asan 19) strains were harvested at
Table 3 Clinically isolated M. abscessus and M. massiliense









Abbreviations: Type I, M. massiliense Type I strain; Type II, M. massiliense Type II
strain; Type I (R), M. massiliense Type I (rough colony morphology) strain.
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culture media by centrifugation at 4,000 rpm for 15 min.
Each bacterial pellet was suspended in CHCl3/CH3OH
[2:1, v/v; 10 ml/g (wet weight of bacterial pellet)]; soni-
cated two times (pulse for 1 min and stop for 10 sec, total
15 min), and incubated at 4°C overnight. After that, the
suspensions were centrifuged to remove insoluble material
and subjected to biphasic partitioning in CHCl3/CH3OH/
H2O (4:2:1, v/v). Total lipid extracts were treated with an
equal volume of NaOH (0.2 M in CH3OH, 45 min at
37°C), neutralized with glacial acetic acid, and dried
in air. Finally, GPLs were extracted in CH3Cl/CH3OH
(2:1, v/v) [17,38,39].Matrix-Assisted Laser Desorption Ionization-Time of Flight
(MALDI-TOF) mass spectrometry analysis
MALDI-TOF mass spectrometry was performed on the
extracted GPLs with a Voyager DE-STR MALDI-TOF
instrument (Perseptive Biosystems) equipped with a
pulse nitrogen laser emitting at 337 nm as previously de-
scribed [24,40].Genome analysis of GPL biosynthesis related gene loci
comparing M. massiliense Asan 50594 and other RGMs
The comparative genomic analysis was performed via
comparison of pairwise alignments between the amino
acid sequences of the GPL biosynthesis related 29 genes
of M. abscessus CIP 104536T (GenBank Accession No.,
NC_010397), M. massiliense CCUG 48898T (GenBank
Accession No., AKVF00000000), M. massiliense Type II
Asan 50594 (GenBank Accession No., CP004374), M. che-
lonae CIP 104535T (GenBank Accession No., AM231610-
AM231615) and M. smegmatis str. MC2 155 (GenBank
Accession No., AY439015) [13,21,22]. The comparative
genomic analysis was performed by pairwise alignments
between the amino acid sequences of the GPL biosyn-
thesis related genes of M. massiliense Type II Asan 50594
and the other RGMs mentioned above. Comparisons were
performed using the MegAlign [41] and BLASTP program(http://blast.ncbi.nlm.nih.gov/Blast.cgi), and percentage of
identities for genes were calculated.
PCR applications targeting 12 GPL biosynthesis related
genes
Total DNA was extracted from colonies using the bead
beater-phenol extraction method, and then used as tem-
plates for PCR. To check the presence of GPL biosyn-
thesis related genes in M. abscessus complex strains, we
used purified DNAs from 76 clinical isolates, which in-
cluded 33 M. massiliense Type I (21 strains: smooth, 12
strains:rough), 21 M. massiliense Type II (rough), and 22
M. abscessus (11 strains: smooth, 11 strains: rough)
(Additional file 4). Using the M. abscessus CIP 104536T
(GenBank Accession No., NC_010397) and M. massilense
CCUG 49989T (GenBank Accession No., AKVF00000000)
genome sequences [13,22], 12 primer sets were designed
(Additional file 2). To amplify 12 independent genes from
the DNA of M. massiliense and M. abscessus clinical iso-
lates, the template DNA (50 ng) and 20 pmol of each pri-
mer were added into a PCR mixture tube (AccuPower
PCR PreMix; Bioneer, Daejeon, South Korea) containing
one unit of Taq DNA polymerase, 250 μM of deoxynu-
cleotide triphosphate, 10 mM Tris–HCl (pH 8.3), 10 mM
KCl, 1.5 mM MgCl2, and gel loading dye. The final
volume was adjusted to 20 μl with distilled water, and the
reaction mixture was then amplified as follows: denatur-
ation at 95°C (5 min); 30 cycles of denaturation at 95°C
(30 sec), annealing at 62°C (30 sec), elongation at 72°C
(45 sec), and final elongation at 72°C (5 min) – using a
model 9700 Thermocycler (Perkin-Elmer Cetus). Also, as
a negative control, distilled water was amplified using all
the primer sets. After amplification, the mixtures were
electrophoresed in 1.5% agarose gel with GeneRuler™
100 bp DNA ladder marker (Thermo Scientific, Pittsburgh,
PA, United States).
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article and its additional files (Additional
files 1, 2, 3 and 4).
Additional files
Additional file 1: MALDI-TOF mass spectrometry profiles of GPLs
from M. massiliense Type I and Type II strains: (A) M. massiliense Type I
Asan 50375, (B) M. massiliense Type I Asan 52352, (C) M. massiliense
Type I Asan 7, (D) M. massiliense Type I Asan 15, (E) M. massiliense
Type II Asan 51048, (F) M. massiliense Type II Asan 52012, (G) M.
massiliense Type II Asan 1, (H) M. massiliense Type II Asan 19.
Additional file 2: List of primers used in this study.
Additional file 3: Confirmation the deleted GPL biosynthesis
related genes by PCR among clinical isolated M. massiliense and M.
abscessus. M, 100 bp DNA ladder; Lane 1, M. massiliense Type I Asan
51843; Lane 2, M. massiliense Type I Asan 50375; Lane 3, M. massiliense
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7, M. massiliense Type I (rough) Asan 22; Lane 8, M. massiliense Type I
(rough) Asan 23; Lane 9, M. massiliense Type I (rough) Asan. 54790; Lane
10, M. abscessus (smooth) Asan 57214; Lane 11, M. abscessus (smooth)
Asan 57388; Lane 12, M. abscessus (smooth) Asan 58417; Lane 13, M.
abscessus (rough) Asan 55088; Lane 14, M. abscessus (rough) Asan 56232;
Lane 15, M. abscessus (rough)Asan 56544; N, negative control.
Additional file 4: List of clinical isolates used in this study.
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